Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC) Share News

12345678910

Syncona To Reduce Fund Investments And Increase Weighting To Cash

12th Mar 2019 09:06

LONDON (Alliance News) - Life sciences investor Syncona Ltd on Tuesday said it will significantly reduce its fund investments over the next three to six months as it works to simplify the of its a Read More

WINNERS & LOSERS SUMMARY: DMGT Rises, Euromoney Falls On Share Return

4th Mar 2019 10:41

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday:----------FTSE 100 - up 4.2%. Shares in the company were from on - Read More

Syncona To Gain GBP255 Million From Nightstar Acquisition By Biogen

4th Mar 2019 09:17

LONDON (Alliance News) - Syncona Ltd on Monday said investee company Nightsar Therapeutics PLC has agreed to be acquired by neuroscience healthcare firm Biogen Inc for USD877 million, giving a 72% Read More

Syncona's Autolus Therapeutics Reports Progress On Therapy Development

3rd Dec 2018 09:05

LONDON (Alliance News) - FTSE 250-listed healthcare-focused investor Syncona Ltd on Monday reported on progress made by portfolio company, Nasdaq-listed Autolus Therapeutics Inc, on its has dosed Read More

Syncona Profit Jumps On Fair Value Gains In Life Sciences Portfolio

21st Nov 2018 09:14

LONDON (Alliance News) - Syncona Ltd on Wednesday reported a more than doubled profit for the first half of its financial year, boosted by fair value gains amid a strong total return for the the a Read More

Syncona Invests Further USD18 Million In NASDAQ-Listed Nightstar (ALLISS)

28th Sep 2018 09:58

LONDON (Alliance News) - Healthcare-focused investment firm Syncona Ltd said Friday it has invested a further USD18 million in NASDAQ-listed Nightstar Therapeutics PLC after its announced a share Read More

Syncona's Nightstar Reports Positive Results From NSR-RPGR Trial

24th Sep 2018 08:44

LONDON (Alliance News) - FTSE 250-listed healthcare investor Syncona Ltd said on Monday its portfolio company Nightstar Therapeutics PLC reported positive results from the dose escalation study in Read More

Syncona Net Asset Value Climbs Amid Burgeoning Life Sciences Portfolio

9th Aug 2018 09:23

LONDON (Alliance News) - Healthcare investor Syncona Ltd said Thursday its net assets increased significantly in its financial first quarter, due to the strong performance and increasing size of a Read More

Syncona Invests GBP85 Million Into Freeline During Funding Round

19th Jun 2018 08:32

LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday it has invested GBP85 million in Adeno-associated virus gene therapy company virus is a small and Read More

Syncona Report 18% Growth In Net Assets As Portfolio Firms Prosper

14th Jun 2018 10:41

LONDON (Alliance News) - Syncona Ltd on Thursday said strong results from its science portfolio and new investments resulted in an increased return for the 2018 financial year.The FTSE life Read More

CORRECT (June 8): Syncona, Woodford And Arix Investee Plans ADS Offer

11th Jun 2018 09:36

(Correcting Syncona and Woodford's shareholding value in Autolus Therapeutics following the ADS offering)LONDON (Alliance News) - Healthcare investor Syncona Ltd said Friday that its an Read More

Syncona Investee Autolus Therapeutics Planning Nasdaq Listing (ALLIPO)

8th May 2018 09:47

LONDON (Alliance News) - Healthcare investor Syncona Ltd on Tuesday noted the proposed listing of American depositary shares on the Nasdaq Global Market by investee Autolus Therapeutics said the Read More

Syncona's Blue Earth Signs Licence For Prostate Cancer Imaging Agent

2nd May 2018 10:32

LONDON (Alliance News) - Life science focused investment trust Syncona Ltd said Wednesday its portfolio company Blue Earth Diagnostics has signed an exclusive licence for a radio-hybride prostate Read More

Syncona's Nightstar 2017 Loss Widens On Research And Development Costs

4th Apr 2018 08:21

LONDON (Alliance News) - Healthcare-focused investment company Syncona Ltd said on Wednesday that itsportfolio company Nightstar Therapeutics PLC reported a widened loss in as Read More

Syncona Revises Investment Management Arrangement To Save Costs

9th Mar 2018 08:43

LONDON (Alliance News) - Syncona Ltd said on Tuesday it has revised its investment management agreement with BACIT UK Ltd in order to reduce costs for has Read More

WINNERS & LOSERS SUMMARY: Investors Lose Appetite For Just Eat

6th Mar 2018 10:38

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Smurfit up it Read More

Syncona And Arix Bioscience Notes Potential US IPO For Autolus (ALLIPO)

6th Mar 2018 09:20

LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday its portfolio company Autolus Ltd, has filed a confidential submission of a Read More

Syncona's Nightstar Begins NSR-REP1 Trial And Appoints New Director

5th Mar 2018 13:07

LONDON (Alliance News) - Healthcare-focused investment company Syncona Ltd said on Monday that portfolio company Nightstar Therapeutics PLC has initiated a STAR Phase Three to Read More

Syncona Takes Advice On FCA's Pooled Investment Marketing Restrictions

23rd Jan 2017 17:09

Read More

12345678910
FTSE 100 Latest
Value8,850.63
Change-34.29